In June 2011, the specialists of the world’s leading manufacturer of high-quality plasma medicines, the Octapharma Company, performed external audit of the LUMIER PHARMA LLC. Based on the results of the audit, Octapharma experts have established that the audited company has successfully implemented and documented a quality control system in conformity with EU GMP requirements.
28 July 2011